Cubist Systematic Strategies’s Ultragenyx Pharmaceutical RARE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.1M | Sell |
85,282
-36,228
| -30% | -$1.32M | 0.01% | 610 |
|
2025
Q1 | $4.4M | Buy |
+121,510
| New | +$4.4M | 0.03% | 468 |
|
2024
Q4 | – | Sell |
-183,490
| Closed | -$10.2M | – | 2159 |
|
2024
Q3 | $10.2M | Buy |
+183,490
| New | +$10.2M | 0.06% | 175 |
|
2024
Q2 | – | Sell |
-22,631
| Closed | -$1.06M | – | 2387 |
|
2024
Q1 | $1.06M | Buy |
+22,631
| New | +$1.06M | 0.01% | 1124 |
|
2023
Q4 | – | Sell |
-29,178
| Closed | -$1.04M | – | 2560 |
|
2023
Q3 | $1.04M | Sell |
29,178
-133,156
| -82% | -$4.75M | 0.01% | 1036 |
|
2023
Q2 | $7.49M | Sell |
162,334
-70,634
| -30% | -$3.26M | 0.05% | 356 |
|
2023
Q1 | $9.34M | Buy |
232,968
+7,769
| +3% | +$312K | 0.06% | 315 |
|
2022
Q4 | $10.4M | Sell |
225,199
-19,380
| -8% | -$898K | 0.06% | 289 |
|
2022
Q3 | $10.1M | Buy |
244,579
+231,245
| +1,734% | +$9.58M | 0.06% | 342 |
|
2022
Q2 | $796K | Sell |
13,334
-26,819
| -67% | -$1.6M | ﹤0.01% | 2271 |
|
2022
Q1 | $2.92M | Buy |
40,153
+32,913
| +455% | +$2.39M | 0.02% | 1175 |
|
2021
Q4 | $609K | Sell |
7,240
-32,208
| -82% | -$2.71M | 0.01% | 2305 |
|
2021
Q3 | $3.56M | Sell |
39,448
-143,360
| -78% | -$12.9M | 0.04% | 652 |
|
2021
Q2 | $17.4M | Buy |
182,808
+148,274
| +429% | +$14.1M | 0.2% | 78 |
|
2021
Q1 | $3.93M | Sell |
34,534
-38,715
| -53% | -$4.41M | 0.05% | 571 |
|
2020
Q4 | $10.1M | Buy |
73,249
+39,317
| +116% | +$5.44M | 0.14% | 155 |
|
2020
Q3 | $2.79M | Buy |
+33,932
| New | +$2.79M | 0.04% | 705 |
|
2020
Q2 | – | Sell |
-10,863
| Closed | -$483K | – | 2506 |
|
2020
Q1 | $483K | Sell |
10,863
-9,093
| -46% | -$404K | 0.01% | 1276 |
|
2019
Q4 | $852K | Sell |
19,956
-17,346
| -47% | -$741K | 0.02% | 1261 |
|
2019
Q3 | $1.6M | Buy |
37,302
+34,396
| +1,184% | +$1.47M | 0.03% | 735 |
|
2019
Q2 | $185K | Buy |
+2,906
| New | +$185K | ﹤0.01% | 2074 |
|
2019
Q1 | – | Sell |
-19,929
| Closed | -$867K | – | 2391 |
|
2018
Q4 | $867K | Buy |
19,929
+11,709
| +142% | +$509K | 0.04% | 633 |
|
2018
Q3 | $628K | Buy |
+8,220
| New | +$628K | 0.03% | 687 |
|
2018
Q2 | – | Sell |
-2,592
| Closed | -$132K | – | 1995 |
|
2018
Q1 | $132K | Sell |
2,592
-3,185
| -55% | -$162K | 0.01% | 1538 |
|
2017
Q4 | $268K | Sell |
5,777
-3,510
| -38% | -$163K | 0.01% | 1332 |
|
2017
Q3 | $495K | Buy |
9,287
+3,717
| +67% | +$198K | 0.03% | 837 |
|
2017
Q2 | $346K | Buy |
5,570
+2,538
| +84% | +$158K | 0.02% | 948 |
|
2017
Q1 | $206K | Buy |
+3,032
| New | +$206K | 0.01% | 1166 |
|
2016
Q2 | – | Sell |
-6,921
| Closed | -$438K | – | 1845 |
|
2016
Q1 | $438K | Buy |
6,921
+3,472
| +101% | +$220K | 0.03% | 815 |
|
2015
Q4 | $387K | Sell |
3,449
-8,851
| -72% | -$993K | 0.02% | 962 |
|
2015
Q3 | $1.19M | Buy |
+12,300
| New | +$1.19M | 0.06% | 477 |
|
2015
Q2 | – | Sell |
-14,808
| Closed | -$919K | – | 2004 |
|
2015
Q1 | $919K | Buy |
14,808
+4,356
| +42% | +$270K | 0.05% | 618 |
|
2014
Q4 | $459K | Buy |
+10,452
| New | +$459K | 0.02% | 914 |
|